Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer
Authors:
- Sergio Carlos NahasSNSergio Carlos Nahas
- Caio Sergio Rizkallah NahasCNCaio Sergio Rizkallah Nahas
- Gerson Montoya CamaGCGerson Montoya Cama
- Rodrigo Lautert de AzambujaRARodrigo Lautert de Azambuja
- Natally HorvatNHNatally Horvat
- Carlos Frederico Sparapan MarquesCMCarlos Frederico Sparapan Marques
- Marcos Roberto MenezesMMMarcos Roberto Menezes
- Ulysses Ribeiro JuniorUJUlysses Ribeiro Junior
- Ivan CecconelloICIvan Cecconello
- 21 January 2019
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 44 (11) , 3632-3640
Abstract
Purpose Our study aimed to evaluate the diagnostic performance of rectal magnetic resonance imaging (MRI) for local restaging in patients with non-metastatic locally advanced rectal cancer (LARC) after neoadjuvant chemoradiotherapy (CRT) using surgical histopathology of total mesorectal excision as the reference standard. Methods Ninety-five patients with LARC who underwent rectal MRI after CRT between January 2014 and December 2016 were included. Accuracy, sensitivity, specificity, positive, and negative predictive value for local staging regarding T-stage, N-stage, circumferential resection margin, and MRI tumor regression grade (ymriTRG) were calculated, and inter-test agreements were assessed. Results 22/95 (23.2%) patients had radiological complete response (rCR), whereas 20/95 (21.1%) had pathological complete response (pCR). Among the patients with pCR, 11/20 (55%) had rCR. Fair agreement was demonstrated between ymriTRG and pathological TRG (ypTRG) (κ = 0.255). The sensitivity and specificity for detection of pCR were 61.1% (95% CI 35.7–82.7) and 89.6% (95% CI 80.6–95.4). For the detection of ypTRG grades 1 and 2, the corresponding values were 67.2% (95% CI 54.3–78.4) and 51.6 (95% CI 33.1–69.8). The accuracy of ymriTRG was 24.2% (95% CI 15.6–32.8). Inter-test agreement in TRG between MRI and pathology was overall fair (κ = 0.255) and slight (κ = 0.179), if TRG 1 + 2. Conclusion Qualitative assessment on MRI for diagnosing pCR showed moderate sensitivity and high specificity, whereas the diagnosis of TRG had moderate sensitivity and low specificity with slight to fair inter-test agreement when compared with pathological specimens.Keywords
This publication has 34 references indexed in Scilit:
- Comparison of Magnetic Resonance Imaging and Histopathological Response to Chemoradiotherapy in Locally Advanced Rectal CancerAnnals of Surgical Oncology, 2012
- Magnetic Resonance Imaging–Detected Tumor Response for Locally Advanced Rectal Cancer Predicts Survival Outcomes: MERCURY ExperienceJournal of Clinical Oncology, 2011
- Downstaging After Chemoradiotherapy for Locally Advanced Rectal Cancer: Is There More (Tumor) Than Meets the Eye? Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye?Diseases of the Colon & Rectum, 2010
- A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant ChemoradiotherapyAnnals of Surgical Oncology, 2008
- An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal CancerAnnals of Surgical Oncology, 2008
- The Swedish rectal cancer registryBritish Journal of Surgery, 2007
- Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation TherapyAnnals of Surgery, 2004
- Low rectal cancerDiseases of the Colon & Rectum, 1998
- RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCERThe Lancet, 1986
- Prolongation of the Disease-Free Interval in Surgically Treated Rectal CarcinomaNew England Journal of Medicine, 1985